EMKR EMCORE Corporation

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

May 20, 2024

Date of Report (Date of earliest event reported)

 

 

 

EMCORE CORPORATION

Exact Name of Registrant as Specified in its Charter

 

New Jersey	001-36632	22-2746503
State of Incorporation	Commission File Number	IRS Employer Identification Number

 

450 Clark Dr., Budd Lake, NJ  07828

Address of principal executive offices, including zip code

 

(626) 293-3400

Registrant's telephone number, including area code

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, no par value	EMKR	The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

Item 2.05      Costs Associated with Exit or Disposal Activities

 

On May 23, 2024, EMCORE Corporation (the “Company”) announced a restructuring program (collectively, the "Restructuring") that includes the full closure of the Company’s Alhambra, CA facility, headcount reductions and additional reductions in operating expenses. On May 20, 2024, the Restructuring Committee of the Company’s Board of Directors approved the Restructuring. Prior to the decision to effect the Restructuring, the Company performed a thorough review of a number of factors including the Company’s competitive landscape, expected revenue and profitability, and cost structure, and concluded that the Company’s current structure and operations would not allow the Company to achieve profitable growth and cash generation. The Company expects the full closure of the Alhambra facility to be completed during the quarter ending September 30, 2024. As a result of the Restructuring, the Company expects to eliminate approximately 120 positions across all locations, collectively representing approximately 40% of the Company’s workforce, and to consolidate facility space by shutting down its operations at the Alhambra facility and seeking to sublease available space in such facility.

 

The personnel reduction actions that are being undertaken by the Company in connection with the Restructuring are expected to result in annualized cost savings of approximately $17.0 million, exclusive of severance costs. At the time of the filing of this Current Report on Form 8-K, the Company is unable in good faith to make a determination of an estimate of the total amount or range of amounts expected to be incurred by the Company in connection with the Restructuring. However, the Company anticipates that material cash and non-cash charges will be incurred and recorded in the Company's future reporting periods, including, without limitation, one-time employee severance and termination costs related to the Restructuring of approximately $1.8 million (including costs pursuant to the Rittichier Separation Agreement (as defined below)). The Company expects to recognize substantially all of these charges in the quarter ending June 30, 2024. The Company may incur additional expenses in connection with the Restructuring that are not currently contemplated. The charges that the Company expects to incur in connection with the Restructuring are estimates and subject to a number of assumptions, and actual results may differ materially.

 

This Item 2.05 contains forward-looking statements that are intended to be covered by the safe harbor for “forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. Words such as “expects,” “believes,” “will,” “may,” “anticipates,” “intends,” “plans,” “estimates,” “seek,” “predict,” “project,” “potential” or the negatives of these terms or variations of them or similar expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding: the Company’s potential future revenue and cost savings projections, expected costs related to the Restructuring; expectations related to employee termination, closure and consolidation of facilities; including the timing thereof, timing of completion of the Restructuring and timing of recognizing charges related to the Restructuring; and the Company’s expectations regarding material cash and non-cash charges. These statements are based on various assumptions, whether or not identified in this Current Report on Form 8-K, and on the current expectations of the Company’s management and are not predictions of actual performance. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements, including but not limited to risks related to our ability to successfully achieve the benefits of the Restructuring and the efficiencies related to a restructuring and reorganization, as well as other risks discussed under the heading "Risk Factors" in the Company’s Annual Report on Form 10-K for the year ended September 30, 2023, filed with the Securities and Exchange Commission (the “SEC”) on December 27, 2023, the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2023, filed with the SEC on February 12, 2024, the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, filed with the SEC on May 14, 2024, and other filings the Company makes with the SEC in the future. You should not place undue reliance on such information and estimates because they may prove to be materially inaccurate. While the Company believes that such information and estimates are based on reasonable assumptions, actual results may vary, and such variations may be material. The Company does not assume any obligation to update any forward-looking statements, except as required by law.

 

 

Item 5.02      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(e)            Effective on May 7, 2024 (the “Separation Date”), Jeffrey Rittichier departed as Chief Executive Officer and director of the Company. In connection with Mr. Rittichier’s departure from the Company, on May 21, 2024, the Company and Mr. Rittichier entered into a Separation and General Release Agreement (the “Rittichier Separation Agreement”). Pursuant to the Rittichier Separation Agreement and consistent with the terms of Mr. Rittichier’s Employment Agreement, dated December 10, 2014, and previously filed with the SEC as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 11, 2014, Mr. Rittichier will receive the following: (i) continuation of his biweekly base salary for a period of twelve months following the Separation Date,;(ii) payment of his target bonus for the fiscal year ending September 30, 2024 in an amount equal to $500,000, payable in equal biweekly payments for a twelve month period; and (iii) reimbursement by the Company of the portion of Mr. Rittichier’s COBRA premiums for up to a maximum of eighteen (18) months that the Company would have otherwise paid as the Company’s contribution to the payment of Mr. Rittichier’s health insurance premium assuming Mr. Rittichier was an active employee during such time. Mr. Rittichier’s outstanding equity awards that remained unvested as of the Separation Date will be cancelled and terminated. Mr. Rittichier’s receipt of the foregoing severance benefits is subject to his compliance with certain confidentiality, non-solicitation and other restrictive covenants as provided in the Rittichier Separation Agreement.

 

Item 9.01      Financial Statements and Exhibits.

 

(d)

Exhibits

 

Exhibit No.		Description
10.1		Separation and General Release Agreement, dated May 21, 2024, by and between EMCORE Corporation and Jeffrey Rittichier.
99.1		Press Release, dated May 23, 2024.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	EMCORE CORPORATION
	By:	/s/ Tom Minichiello
Dated: May 23, 2024
	Name: Tom Minichiello
	Title:   Chief Financial Officer

 

 

 

 

Exhibit 10.1 

 

SEPARATION AND GENERAL RELEASE AGREEMENT

 

This Separation and General Release Agreement (the “Agreement”) is entered into by and between EMCORE Corporation (the “Company”) and Jeffrey Rittichier (“Employee”) (collectively, the “Parties”).

 

In consideration of the mutual promises and covenants contained in this Agreement, Employee and the Company agree as follows:

 

1.             Effective Date: This Agreement will become effective on the eighth day after it is signed by Employee and delivered to the Company (the “Effective Date”), provided that (a) it is signed and returned to the Company on or before May 24, 2024, and (b) it is not revoked by Employee prior to the Effective Date pursuant to Section 7 below.

 

2.             Acknowledgement of Receipt of Amounts Owed on Separation: Employee understands and acknowledges that the employment relationship between the Company and Employee is terminated effective May 7, 2024 (the “Separation Date”). Following the Separation Date, Employee and the Company will have no further employment or contractual relationship except as may arise out of this Agreement. Employee acknowledges that Employee received, by no later than the Separation Date, all (a) amounts currently owed for services performed up through and including the Separation Date (including, but not limited to, any overtime, bonus, commissions, or other wages), and (b) accrued but unused vacation up through and including the Separation Date. Employee acknowledges he will be eligible to exercise his rights to COBRA health insurance coverage for Employee, and, where applicable, Employee’s spouse and eligible dependents, at Employee’s expense (subject to the following provision), upon termination of Executive’s employment. Employee agrees and acknowledges that any dispute related to the payment of wages or other compensation to Employee is hereby resolved to Employee’s complete and full satisfaction. Employee agrees that California Labor Code section 206.5 is not applicable because there is no good faith dispute as to whether Employer owes Employee any wages. Section 206.5 provides, in pertinent part, as follows: “An employer shall not require the execution of a release of claim right on account of wages due, or to become due, or made as an advance on wages to be earned, unless payment of those wages has been made.”

 

Employee’s rights with respect to any Restricted Stock Units (“RSUs”) shall remain subject to the terms of the applicable Time-Based Restricted Stock Unit Award Agreement or Performance-Based Restricted Stock Unit Award Agreement. Any outstanding RSUs that have not vested as of the Separation Date shall be cancelled as of the Separation Date and Employee shall have no further rights with respect to any equity awards.

 

3.             Consideration: Provided that Employee (a) executes and delivers this Agreement to the Company’s General Counsel (at legal@emcore.com or 2015 Chestnut Street, Alhambra, CA 91803), by no later than May 24, 2024, at 5:00 p.m., (b) is not in breach or default of this Agreement, (c) has performed all obligations under this Agreement, and (d) has not revoked this Agreement pursuant to Section 6 below, the Company will provide to Employee the following severance benefits:

 

a.            Base Pay Severance: The Company will pay to Employee cash severance in an amount equal to $500,000.00, less standard withholdings and authorized deductions. The cash severance payment(s) will be paid in equal bi-weekly payments on the regular paydays of the Company in accordance with the Company’s standard payroll practices for a period beginning on the first regular payroll cycle after the Effective Date of this Agreement and continuing for a twelve-month (12) period thereafter (the “Severance Period”). All voluntary payroll deductions, including but not limited to 401(k), ESPP and term life, will cease effective on the employment Separation Date and will not be deducted from the severance payments.

 

b.             Bonus Severance Payment: The Company will pay to Employee a severance bonus in an amount equal to 100% of Employee’s base salary in the amount of $500,000.00, less standard withholdings and authorized deductions. The bonus severance payment(s) will be paid in equal bi-weekly payments on the regular paydays of the Company in accordance with the Company’s standard payroll practices for a period beginning on the first regular payroll cycle after the Effective Date of this Agreement and continuing for the remainder of the Severance Period.

 

 

c.            Benefits Continuation: To the extent Employee elects COBRA continuation coverage, the Company shall continue to pay the portion of Employee’s COBRA premiums for up to a maximum of eighteen (18) months (“COBRA Period”) that the Company would have otherwise paid as the Employer’s contribution to the payment of the Employee’s premium assuming Executive was an active employee during such time. Employee acknowledges that as a condition of the Company’s payment of its portion of the COBRA premium, Employee will pay by check made payable to the Company the amount equal to Employee’s portion of the COBRA premiums owed during the COBRA Period.  Nothing herein shall be construed as extending or delaying the start date of the COBRA coverage period for Employee.

 

D.           Employee acknowledges and agrees that the severance benefits set forth in Section 3(a), 3(b) and 3(c) are in full satisfaction of any amount otherwise payable under the Employee’s Employment Agreement with the Company and that Employee has no entitlement to additional severance or termination benefits.

 

E.            Company acknowledges and agrees that the Consideration in Sections 3(a), 3(b) and 3(c) is a primary inducement for the Employee to enter into this Agreement. Should the Company breach these Consideration obligations to Employee either voluntarily or through any filing under the US Bankruptcy Code, this entire agreement shall be null and void.

 

4.            Transition Assistance and Ongoing Cooperation: In exchange for the severance benefits set forth in this Agreement, on the Effective Date of this Agreement, Employee agrees to make himself reasonably available for no more than ten (10) hours per month to (i) assist in analyzing cost reduction plans proposed by the Restructuring Committee of the Company’s Board of Directors; and (ii) provide general transition assistance as directed by the Restructuring Committee (“Transition Assistance”) for six (6) months following the Separation Date (the “Transition Period”). Employee acknowledges and agrees that the severance benefits set forth in this Agreement constitute adequate and reasonable consideration for the anticipated Transition Assistance during the Transition Period. Employee acknowledges that failure to provide reasonable assistance during the Transition Period could result in the termination of severance benefits as set forth in this Agreement.

 

5.            Releases and Waivers: In consideration of the covenants undertaken herein by the Company, and except for those obligations created by or arising out of this Agreement, Employee, on Employee’s own behalf and on behalf of Employee’s descendants, dependents, marital community, heirs, executors, administrators, assigns and successors, and each of them, does hereby covenant never to sue and acknowledges complete satisfaction of and hereby fully and forever releases, absolves and discharges the Company, and the Company’s parent, subsidiary, and affiliated corporations, businesses and partnerships, past, present, and future, and all of its and their trustees, directors, officers, shareholders, partners, agents, employees, representatives, attorneys, insurers, employee benefits plans (including the past, present, and future trustees, administrator’s fiduciaries, and insurers thereof), past and present, as well as the heirs, executors, administrators, predecessors, successors and assignees of all of the foregoing, and each of them (collectively “Releasees”) with respect to and from any and all claims, demands, rights, liens, agreements, contracts, covenants, actions, suits, causes of action, charges, grievances, wages, employment benefits, obligations, debts, litigation and/or other costs, expenses, attorneys’ fees, damages, penalties, judgments, orders and liabilities of whatever kind or nature in law, equity or otherwise, whether now known or unknown, suspected or unsuspected, and whether or not concealed or hidden, which Employee now owns or holds or has at any time heretofore owned or held as against Releasees, or any of them, arising out of or in any way connected with or related to or concerning Employee’s employment relationship with the Company (and/or any other Releasees), or Employee’s separation from employment, or any other transactions, occurrences, acts or omissions or any loss, damage or injury whatever, known or unknown, suspected or unsuspected, resulting from any act or omission by or on the part of said Releasees, or any of them, committed or omitted prior to the date of this Agreement, including specifically, but without limiting the generality of the foregoing, any and all claims for wages of any type, overtime compensation, rest or meal period payments, severance pay, including but not limited pursuant to the Company’s Severance Pay Plan for Employees, bonus pay, incentive pay, sick leave, sick pay, holiday pay, vacation pay, life insurance, health and medical insurance or any other fringe benefit, or disability benefit, including, but not limited to, any and all claims under any local, state or federal statutory, administrative, or common laws related to such claims or in any manner related to working conditions; retaliation, discrimination, harassment, wrongful termination, or any other violation under any local, state or federal law, regulation, or ordinance (including, but not limited to, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Family and Medical Leave Act, the Fair Labor Standards Act, the National Labor Relations Act, the Worker Adjustment Retraining and Notification Act, the Employee Retirement Income Security Act, the California Fair Employment and Housing Act, the California Family Rights Act, the California Labor Code, the California Private Attorneys General Act and/or wrongful termination, breach of express and/or implied-in-fact contract, breach of the covenant of good faith and fair dealing, unpaid wages, violation of public policy, intentional and/or negligent infliction of emotional distress, defamation, invasion of privacy, fraud and/or negligent misrepresentation, negligent supervision and/or retention, intentional and/or negligent interference with contractual relations and/or prospective economic advantage, and other common law torts (“Release”). Nothing in the foregoing release is intended to relieve the Company of any claim that may not be released as a matter of applicable law.

 

 

6.            Waiver of Civil Code Section 1542: It is a condition of this Agreement and is the intention of Employee in executing this Agreement that the same shall be effective as a bar as to each and every claim, demand and cause of action specified above and, in furtherance of this intention, Employee hereby expressly waives any and all rights or benefits conferred by the provisions of CALIFORNIA CIVIL CODE SECTION 1542 and expressly consents that this Agreement shall be given full force and effect according to each and all of its express terms and conditions, including those relating to unknown and unsuspected claims, demands and causes of actions, if any, as well as those relating to any other claims, demands and causes of actions specified above. CALIFORNIA CIVIL CODE SECTION 1542 provides:

 

“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.”

 

Employee acknowledges that Employee may later discover claims or facts in addition to or different from those which Employee now knows or believes to exist with respect to the subject matter of this Agreement and which, if known or suspected at the time of executing this Agreement, may have materially affected this Agreement. Nevertheless, Employee hereby waives any right, claim or cause of action that might arise as a result of such different or additional claims or facts. Employee acknowledges that Employee understands the significance and consequence of such release and such specific waiver of CALIFORNIA CIVIL CODE SECTION 1542.

 

7.            Waiver of Rights Under Age Discrimination in Employment Act of 1967: Employee expressly acknowledges and agrees that, by entering into this Agreement, Employee is waiving and releasing any rights or claims that Employee may have arising under the Age Discrimination in Employment Act of 1967 (“ADEA”), as amended, which may have arisen on or before the date of execution of this Agreement, and that this waiver and release is knowing and voluntary. Employee also expressly acknowledges and agrees that:

 

a.            In return for this waiver and release, Employee will receive consideration, i.e., something of value, beyond that to which Employee was already entitled;

 

b.            Employee is hereby advised in writing by this Agreement to consult with an attorney before signing this Agreement;

 

c.            Employee was informed, and is informed by this writing, that Employee may take up to twenty-one (21) days within which to consider this Agreement. In the event this Agreement is signed prior to the expiration of 21 calendar days, Employee acknowledges that Employee voluntarily and knowingly agrees to waive Employee’s entitlement to take up to 21 days to consider this Agreement for the purpose of expediting the settlement;

 

d.            Employee was informed, and is informed by this writing, that Employee has seven (7) days following Employee’s execution of this Agreement in which to revoke this Agreement; and that this Agreement will not become effective or enforceable until the revocation period has expired. If Employee revokes the Agreement during the seven-day revocation period, this Agreement shall become null and void.

 

 

e.            In the event Employee signs this Agreement and returns it to the Company in less than the 21-day period identified above, Employee hereby acknowledges that Employee has freely and voluntarily chosen to waive the time period allotted for consideration of this Agreement. As explained above, Employee may revoke this Agreement in its entirety during the seven (7) days following Employee’s execution of it. Any revocation of this Agreement must be in writing and received by the Company’s General Counsel, delivered on or before the seven-day revocation period. This Agreement will become effective and enforceable on the eighth day following execution by Employee, unless Employee revokes it during that period consistent with the terms of this Section. The Parties agree that no change to this Agreement, whether material or immaterial, will restart the running of the twenty-one (21) day period. In the event that Employee exercises Employee’s right of revocation during the seven-day revocation period, neither the Company nor Employee will have any obligations under this Agreement. Nothing in this Agreement prevents or precludes Employee from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized by federal law.

 

8.            Denial of Liability: While this Agreement resolves all issues that the Parties may have with each other, it does not constitute an admission by either Party or the company’s employees or agents of any violation of any federal, state or local law, ordinance or regulation, or of any violation of the Company’s policies or procedures or of any liability or wrongdoing whatsoever. Neither this Agreement nor anything in this Agreement shall be construed to be, or shall be admissible in any proceeding as, evidence of liability or wrongdoing by either Party, including any of the Company’s employees or agents. This Agreement may be introduced, however, in any proceeding to enforce the Agreement. Such introduction shall be pursuant to an order protecting its confidentiality.

 

9.            Warranty Regarding Non-Assignment: Employee warrants and represents that Employee has not assigned or transferred to any person not a party to or intended beneficiary of this Agreement any released matter or any part or portion thereof, and that Employee shall defend, indemnify and hold harmless the Company (and all other Releasees) from and against any claim (including the payment of attorneys’ fees and costs actually incurred whether or not litigation is commenced) based on or in connection with or arising out of any such assignment or transfer made, purported or claimed.

 

10.          Confidentiality:

 

a.            The Parties agree to keep the existence and terms of this Agreement in the strictest confidence and, except as required by law, not reveal the existence or terms of this Agreement to any persons except the Company’s Board of Directors, both Parties counsel, Employee’s immediate family, and Employee’s financial advisors (and to them only provided that they also agree to keep the information completely confidential), and an arbitrator in any proceedings to enforce the terms of this Agreement. Nothing in this Agreement, however, shall be construed to preclude either Party from complying with a lawful court order or process requiring disclosure, written, oral or otherwise, of any confidential information, provided that Employee follows the procedures set forth in Section 11 below. Notwithstanding the foregoing, the Parties agree that the Company shall file this Agreement as an exhibit to a Current Report on Form 8-K (the “Form 8-K”) with the Securities and Exchange Commission within four business days of it becoming fully binding and effective on each of the Parties.

 

b.            Employee acknowledges and agrees that Employee is and will continue after the Separation Date to be subject to certain restrictive covenants and obligations in favor of the Company under nondisclosure, confidentiality, non-solicitation provisions of Article III of the Employment Agreement, or similar agreement(s) with the Company and similar Company policies, including the Confidential Information & Invention Assignment Agreement (collectively, the “Confidentiality Agreements”). Employee agrees that a breach by Employee of the Confidentiality Agreements would cause immediate and irreparable harm to the Company that would be difficult or impossible to measure, and that damages to the Company for any such injury would therefore be an inadequate remedy for any such breach. Therefore, Employee agrees that in the event of any breach or threatened breach by Employee of any provision of the Confidentiality Agreements, the Company, consistent with Section 18, shall be entitled, in addition to all other remedies the Company may have under this Agreement, at law or otherwise, to seek specific performance, injunctive relief and/or other appropriate relief (without posting any bond or deposit) in order to enforce or prevent any violations of any Confidentiality Agreement.

 

 

11.          No Pursuit of Released Claims and Promise not to Cooperate with Others: Except as described below, Employee agrees and covenants not to file any suit, charge, representative action including the California Private Attorneys General Act, class action, or complaint against Releasees in any court or administrative agency, with regard to any claim, demand, liability or obligation arising out of Employee’s employment with Company or separation therefrom. Employee also promises not to voluntarily encourage, counsel or assist (directly or indirectly) any current or former employee or third-party in the preparation or prosecution of any civil dispute, difference, grievance, claim, charge or complaint against the Company and/or any Releasees unless compelled to do so by valid legal process. In the event Employee receives notice that Employee is required to provide testimony or information in any context about the Company and/or any Releasees to any third-party, Employee agrees to inform the Company’s Human Resources Director in writing within seventy-two (72) hours of receiving such notice. Employee, thereafter, agrees to cooperate with the Company in responding (if necessary) to such legal process. Employee also agrees not to testify or provide any information in any context if the Company has informed Employee of its intent to contest the validity or enforceability of any request, subpoena or court order until such time as the Company has informed Employee in writing that it consents to Employee’s testimony or has fully exhausted its efforts to challenge any request, subpoena or court order requiring Employee’s testimony. If Employee is required to provide testimony in any context about the Company (with the Company’s consent or after the Company completes its challenges), Employee shall testify truthfully at all times.

 

Nothing in this Paragraph or this Agreement, however, shall be construed to prohibit Employee from filing a charge with or participating in any investigation or proceeding conducted by the U.S. Equal Employment Opportunity Commission, National Labor Relations Board, or a comparable state or local agency.  Notwithstanding the foregoing, Employee agrees to waive Employee’s right to recover monetary damages in any charge, complaint, or lawsuit filed by Employee with such an administrative agency or by anyone else on Employee’s behalf in any forum, with respect to any and all claims released through this Agreement.

 

12.          Non-disparagement: The Parties agree not to make any oral or written statement, or take any other action (directly or indirectly), that disparages, criticizes, or damages the reputations of either party. This shall be binding upon both parties, including the Company’s officers and directors. Nothing in this Agreement prevents Employee from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that you have reason to believe is unlawful.

 

13.          No Pending or Future Lawsuits: Employee represents that Employee has no lawsuits, claims, or actions pending in Employee’s name, or on behalf of any other person or entity, against the Company or any of the Releasees. Employee also promises to opt out of any class or representative action and to take such other steps as Employee has the power to take to disassociate himself or herself from and waive any rights or remedies that might be received from any class or representative action seeking relief against the Company and/or any other Releasee regarding any of the claims released by this Agreement.

 

14.          Medicare Recital and Indemnification: Employee does hereby represent and warrant to the Company that Employee is not a current Medicare beneficiary, that Employee is not a current recipient of Social Security Disability benefits, that Employee has not applied for Social Security Disability benefits, that Employee has no knowledge of Medicare, or any other governmental entity, paying for any medical treatment relating to any claim arising out of or released by this Agreement. Employee agrees to fully defend, indemnify and hold harmless Releasees and each of them from payment of medical liens, bills, interest and/or penalties that may be or are required of them, associated with any and all claims released under this Agreement, whether or not such liens, bills, interest and/or penalties are being asserted against payments made under this Agreement.

 

15.          Third Party Inquiries: Any third-party inquiries directed to the Company’s Human Resources Department regarding the Employee’s employment will be provided with the following information:  Employee’s name, dates of employment, and last position held.

 

16.          Return of Property: Employee agrees that on or before the Separation Date, Employee will return to the Company any and all documents, software, Company-issued equipment, and all other materials or other things in Employee’s possession, custody, or control, which are the property of the Company, except for the Company-issued laptop and iPad, which Employee shall be allowed to keep in his possession following the removal of Company information by the Company’s IT Department and any materials the Company provides for reference to the Employee during the Transition Period as defined above, which Employee agrees to return immediately following the Transition Period.

 

 

17.          Full and Knowing Waiver and Attorney Review Period: Employee acknowledges that this Agreement constitutes written notice from Employer that he/she has a right to consult an attorney regarding this Agreement, and that he/she has been provided with a reasonable time period of not less than twenty-one (21) days to do so. Employee acknowledges that he/she has fully discussed all aspects of this Agreement with an attorney to the extent he/she desires to do so. Employee acknowledges that he/she may sign this Agreement prior to the termination of the twenty-one (21) day period for reviewing this Agreement, and warrants that any signature prior to the end of twenty-one (21) day period is knowing, voluntary, and has not been induced by Employer through fraud, misrepresentation, a threat by Employer to withdraw or alter the Agreement prior to the expiration of the reasonable time period, or by Employer providing different terms to other employees who sign a similar severance or separation agreement prior to the expiration of such twenty-one (21) day time period.

 

18.          Waiver of Jury Trial: The Parties acknowledge and agree that they are hereby waiving any rights to trial by jury in any action or proceeding brought by either of the Parties against the other in connection with any matter whatsoever arising out of or in any way connected with this Agreement or Employee’s employment with or separation of employment from the Company. Except as prohibited by law, any legal dispute concerning connected with this Agreement or Employee’s employment with or separation of employment from the Company will be resolved through binding arbitration in Los Angeles, California, in accordance with the then current rules issued by the American Arbitration Association (“AAA”) for the resolution of employment disputes, which rules are available for review at www.adr.org/employment and incorporated herein by reference. Judgment upon the award rendered by the arbitrator in such proceeding may be entered in any court having jurisdiction thereof, provided, however, that the law applicable to any issues regarding the scope, effectiveness or interpretation of this arbitration provision shall be the Federal Arbitration Act. Nothing in this arbitration provision is intended to limit any right the Employee may have to file a charge or claim with (or, to the extent not barred by the Release, to obtain relief from) the National Labor Relations Board, or other federal or state agencies. The Parties agree that such arbitration shall be conducted on an individual basis only, not a class, representative or collective basis and hereby waive any right to bring classwide, collective or representative claims before any arbitrator or in any forum. THE PARTIES UNDERSTAND THAT BY AGREEING TO ARBITRATE DISPUTES THEY ARE WAIVING ANY RIGHT THEY MIGHT OTHERWISE HAVE TO A JURY TRIAL. This arbitration provision is not intended to modify or limit substantive rights or the remedies available to the Parties, including the right to seek interim relief, such as injunction or attachment, through judicial process, which shall not be deemed a waiver of the right to demand and obtain arbitration.

 

19.          Integration Clause: This Agreement, along with the Confidentiality Agreement(s) and the nondisclosure, confidentiality, non-solicitation provisions of Article III of Employee’s Employment Agreement, constitute and contain the entire agreement and final understanding concerning Employee’s employment with the Company, the termination of that employment, and the other subject matters addressed in this Agreement. It is intended by the Parties as a complete and exclusive statement of the terms of their agreement. It supersedes and replaces all prior negotiations and all agreements proposed or otherwise, whether written or oral, concerning the subject matters addressed in this Agreement. Any representation, promise or agreement not specifically included in this Agreement shall not be binding upon or enforceable against either party. This Agreement is a fully integrated agreement.

 

20.          Amendment: This Agreement may not be altered, amended, or modified except in writing signed by both Employee and an authorized officer of the Company.

 

21.          Successors: This Agreement shall inure to the benefit and be binding upon the Company and its respective successors and assigns and any such successor or assignee shall be deemed substituted for the Company under the terms of this Agreement for all purposes. As used herein, “successor” and “assignee” shall include any person, firm, corporation, organization, or other entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires the ownership of the Company or to which the Company assigns this Agreement by operation of law or otherwise. This Agreement, however, is personal to Employee and shall not, without the prior written consent of the Company, be assignable by Employee.

 

22.          Severability: If any term or provision of this Agreement or the application thereof is held to be invalid or unenforceable, the invalidity or unenforceability shall not affect any other terms or provisions or applications of this Agreement which can be given effect without the invalid terms or provisions or application, and to this end the terms and provisions of this Agreement are declared to be severable. In other words, if any term or provision of this Agreement is held to be invalid or unenforceable, then the remaining terms and provisions of this Agreement shall continue to be valid and will be performed, construed, and enforced to the fullest extent permitted by law.

 

 

23.          Governing Law: This Agreement shall be deemed to have been executed and delivered within the State of California, and, except for Section 18, which shall be governed by the Federal Arbitration Act (both substantively and procedurally), the rights and obligations of the Parties under this Agreement shall be construed and enforced in accordance with, and governed by, the laws of the State of California without regard to principles of conflict of laws.

 

24.          Counterparts: This Agreement may be executed in counterparts, and each counterpart, when executed, shall have the same effect as a signed original. Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose.

 

25.          Non-Waiver: No waiver of any breach of any term or provision of this Agreement shall be construed to be, or shall be, a waiver of any other breach of this Agreement. No waiver shall be binding unless in writing and signed by the party waiving the breach.

 

26.          Representation: In entering into this Agreement, the Parties warrant and represent that they have completely read and fully understand the terms and consequences of this Agreement, and that they have been given the opportunity to consult with legal counsel of their own choosing regarding this Agreement. Accordingly, the Parties each warrant and represent that the terms of this Agreement are fully understood and freely and voluntarily accepted by them.

 

27.          Cooperation: Each party has cooperated in the drafting of this Agreement. Hence, in any construction to be made of this Agreement, the same shall not be construed against any party on the basis that the party was the drafter. Additionally, the Parties agree to cooperate fully and to execute any and all supplementary documents and to take all additional actions that may be necessary or appropriate to give full force to the basic terms and intent of this Agreement and which are not inconsistent with its terms.

 

28.          Number and Gender: Where context requires, the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders.

 

29.          Headings: The section headings contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement.

 

[Signature Page Follows]

 

 

EXECUTED on 5/21/2024, at Los Angeles County, California.
By:	/s/ Jeffrey Rittichier
	Jeffrey Rittichier
EXECUTED on 5/21/2024, at Los Angeles County, California.
EMCORE CORPORATION
By:	/s/ Ryan Hochgesang
Name:	Ryan Hochgesang
Title:	VP, General Counsel

 

Signature Page to Separation and General Release Agreement

 

 

 

 

Exhibit 99.1

 

EMCORE Restructuring Update: Personnel Reduction and Alhambra Closure

 

Budd Lake, NJ May 23 2024 – EMCORE Corporation (Nasdaq: EMKR), the world’s largest independent provider of inertial navigation solutions to the aerospace and defense industry, today announced personnel and expense reduction actions, including the planned full closure of the Alhambra, CA site.

 

Personnel reductions are expected to result in annualized savings of approximately $17 million and are the first stage of a restructuring program that is expected to include additional actions designed to further reduce annualized operating costs in an expedited manner. While the personnel reductions are significant and represent approximately 40% of EMCORE’s workforce, they are designed to enable EMCORE to execute on its current and planned business base. The Company expects the Alhambra shutdown to be fully completed during the fourth fiscal quarter ending September 30, 2024. Restructuring charges, including severance, facility consolidation, and other related items, are expected to be finalized and recorded in the third fiscal quarter ending June 30, 2024.

 

“This personnel reduction and facility closure represent a critical set of initial steps to achieve adjusted cash flow break even ahead of September 30, 2024” said Cletus Glasener, Chairman of the Board of EMCORE. “These actions and other anticipated cost reduction and performance improvement measures are critical to best position EMCORE for success moving forward.”

 

“The EMCORE Board and leadership team express their sincere gratitude for the service of the individuals affected by these reductions and wish them well,” added Mr. Glasener.

 

About EMCORE

 

EMCORE Corporation is a leading provider of inertial navigation products for the aerospace and defense markets. We leverage industry-leading Photonic Integrated Chip (PIC), Quartz MEMS, Lithium Niobate, and chip-level technology to deliver state-of-the-art component and system-level products across our end-market applications. EMCORE has vertically-integrated manufacturing capability at its facilities in Budd Lake, NJ, Concord, CA, and Tinley Park, IL. Our manufacturing facilities maintain ISO 9001 quality management certification, and we are AS9100 aerospace quality certified in Budd Lake and Concord. For further information about EMCORE, please visit http://www.emcore.com.

 

Forward-Looking Statements

 

The information provided herein may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (“Exchange Act”). These forward-looking statements are largely based on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Such forward-looking statements include, in particular, projections about our future results, including our personnel and expense reduction actions, including the closure of the Alhambra site and the timing thereof, expectations related to the cost savings and the timing of completion of the restructuring, timing of recognizing charges related to the restructuring, expected benefits of the restructuring, our belief that the personnel reduction and facility closure represent a critical set of initial steps to achieve adjusted cash flow break even ahead of September 30, 2024, our belief that the restructuring is critical to best position EMCORE for success moving forward, other anticipated performance improvement measures and statements about our future results of operations and financial position, plans, strategies, business prospects, changes, and trends in our business and the markets in which we operate.

 

These forward-looking statements may be identified by the use of terms and phrases such as “anticipates”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “plans”, “projects”, “targets”, “will”, and similar expressions or variations of these terms and similar phrases. Additionally, statements concerning future matters such as the development of new products, future growth, enhancements or technologies, sales levels, expense levels, and other statements regarding matters that are not historical are forward-looking statements. We caution that these forward-looking statements relate to future events or our future financial performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance, or achievements of our business or our industry to be materially different from those expressed or implied by any forward-looking statements.

 

 

These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, including without limitation, the following: (a) any disruptions to our operations a result of the restructuring; (b) risks related to costs and expenses incurred in connection with restructuring activities and other anticipated performance improvement measures and anticipated operational costs saving arising from the restructuring actions other anticipated performance improvement measures; (c) risks related to the loss of personnel; (d) risks related to customer and vendor relationships and contractual obligations with respect to the shutdown of the Broadband business segment and the discontinuance of its defense optoelectronics product line; (e) risks related to the anticipated scaling of the Company’s inertial navigation business including (i) the rapidly evolving markets for the Company's products and uncertainty regarding the development of these markets, (ii) the Company's historical dependence on sales to a limited number of customers and fluctuations in the mix of products and customers in any period, (iii) delays and other difficulties in commercializing new products, (iv) the failure of new products: (A) to perform as expected without material defects; (B) to be manufactured at acceptable volumes, yields, and cost; (C) to be qualified and accepted by our customers; and (D) to successfully compete with products offered by our competitors, (v) uncertainties concerning the availability and cost of commodity materials and specialized product components that we do not make internally, (vi) actions by competitors, (vii) acquisition-related risks, including that (A) the revenues and net operating results obtained from our recent acquisitions may not meet our expectations, (B) the costs and cash expenditures for integration of our recent acquisitions may be higher than expected, (C) we may not recognize the anticipated synergies from our recent acquisitions, (D) there could be losses and liabilities arising from these acquisitions that we will not be able to recover from any source, and (E) we may not realize sufficient scale from these acquisitions and will need to take additional steps, including making additional acquisitions, to achieve our growth objectives for this product line, (viii) risks related to our ability to obtain capital, (ix) the effect of component shortages and any alternatives thereto, (x) risks and uncertainties related to manufacturing and production capacity and expansion plans related thereto, and (xi) risks related to the conversion of order backlog into product revenue; (f) risks related to the closing the manufacturing support and engineering center in China; and (g) other risks and uncertainties discussed under Item 1A - Risk Factors in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, as updated by our subsequent periodic reports.

 

Forward-looking statements are based on certain assumptions and analysis made in light of our experience and perception of historical trends, current conditions, and expected future developments as well as other factors that we believe are appropriate under the circumstances. While these statements represent our judgment on what the future may hold, and we believe these judgments are reasonable, these statements are not guarantees of any events or financial results. All forward-looking statements in this press release are made as of the date hereof, based on information available to us as of the date hereof, and subsequent facts or circumstances may contradict, obviate, undermine, or otherwise fail to support or substantiate such statements. We caution you not to rely on these statements without also considering the risks and uncertainties associated with these statements and our business that are addressed in our filings with the Securities and Exchange Commission (“SEC”) that are available on the SEC’s web site located at www.sec.gov, including the sections entitled “Risk Factors” in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Certain information included in this press release may supersede or supplement forward-looking statements in our other Exchange Act reports filed with the SEC. We do not intend to update any forward-looking statement to conform such statements to actual results or to changes in our expectations, except as required by applicable law or regulation.

 

Investor Contact:

 

EMCORE Corporation 

Tom Minichiello 

Chief Financial Officer 

investor@emcore.com

 

 

v3.24.1.1.u2

Cover	May 20, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	May 20, 2024
Entity File Number	001-36632
Entity Registrant Name	EMCORE CORP
Entity Central Index Key	0000808326
Entity Tax Identification Number	22-2746503
Entity Incorporation, State or Country Code	NJ
Entity Address, Address Line One	450 Clark Dr.
Entity Address, City or Town	Budd Lake
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07828
City Area Code	626
Local Phone Number	293-3400
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	EMKR
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

---